Why do Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) help in managing Abnormal Uterine Bleeding (AUB)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

NSAIDs are effective in managing Abnormal Uterine Bleeding (AUB) by reducing menstrual blood loss through their inhibition of prostaglandin synthesis, and they can be used for short-term treatment (5-7 days) as recommended by the most recent guidelines 1.

Mechanism of Action

NSAIDs work by blocking cyclooxygenase enzymes, which decreases prostaglandin production in the endometrium. Since elevated prostaglandin levels contribute to excessive uterine contractions and increased blood flow, reducing these levels helps normalize the bleeding pattern.

Commonly Used NSAIDs

Common NSAIDs used for AUB management include ibuprofen (400-600mg three times daily), naproxen (500mg twice daily), or mefenamic acid (500mg three times daily), typically started 1-2 days before menstruation begins and continued throughout the period for maximum effectiveness.

Efficacy and Safety

NSAIDs can reduce menstrual blood loss by 20-50% in many women, making them particularly useful for AUB associated with ovulatory cycles or conditions like adenomyosis and fibroids 1. However, side effects may include gastrointestinal discomfort, so taking these medications with food is recommended. NSAIDs should be used cautiously in patients with kidney disease, peptic ulcers, or bleeding disorders, and they may not be sufficient as sole therapy for severe AUB cases.

Key Considerations

  • Patient Selection: NSAIDs are suitable for short-term use in patients with AUB who do not have contraindications to their use.
  • Dosage and Duration: The recommended duration of NSAID use for AUB is 5-7 days, as indicated in the guidelines 1.
  • Alternative Treatments: For patients who do not respond to NSAIDs or have contraindications, other treatment options such as hormonal therapies or antifibrinolytic agents may be considered, depending on the underlying cause of AUB and patient preferences.

From the Research

Mechanism of NSAIDs in AUB

  • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) help in managing Abnormal Uterine Bleeding (AUB) by reducing prostaglandin levels, which are elevated in women with excessive menstrual bleeding 2, 3, 4, 5.
  • Prostaglandin reduction also has a beneficial effect on dysmenorrhea, making NSAIDs a useful treatment option for women experiencing heavy menstrual bleeding and painful periods 3, 4, 5.

Efficacy of NSAIDs in AUB

  • NSAIDs have been shown to decrease menstrual bleeding by 25-50% in women with AUB 2, 3, 4, 5.
  • While NSAIDs are effective in reducing heavy menstrual bleeding, they are less effective than other treatments such as tranexamic acid, danazol, and the levonorgestrel-releasing intrauterine system (LNG IUS) 3, 5.
  • There is no significant difference in efficacy between individual NSAIDs, such as naproxen and mefenamic acid, in reducing heavy menstrual bleeding 3, 5.

Comparison with Other Treatments

  • NSAIDs are more effective than placebo in reducing heavy menstrual bleeding, but less effective than danazol, which can cause more adverse events 3, 5.
  • There is no significant difference in efficacy between NSAIDs and other medical treatments, such as oral progestogen, ethamsylate, and the oral contraceptive pill, although these results are based on small studies 3, 5.
  • NSAIDs may be a useful treatment option for women with AUB who cannot tolerate other treatments or prefer a non-hormonal approach 4.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Therapies for the treatment of abnormal uterine bleeding.

Current women's health reports, 2001

Research

Non-steroidal anti-inflammatory drugs for heavy menstrual bleeding.

The Cochrane database of systematic reviews, 2013

Research

Pharmacological therapy for abnormal uterine bleeding.

Menopause (New York, N.Y.), 2011

Research

Nonsteroidal anti-inflammatory drugs for heavy menstrual bleeding.

The Cochrane database of systematic reviews, 2000

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.